Here's Looking at You, Big Blue


Carol Kovac, who went to IBM’s computational biology department out of a research background, now heads up the company’s life sciences business unit, launched in August 2000. With a budget of $100 million to invest in partnerships, Big Blue has the resources to be a major player in the bioinformatics arena — and is out to prove that it is one. Kovac recently spoke with GT about her group’s progress, strategy, and outlook after this year’s reconfiguration of the unit.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.